156 related articles for article (PubMed ID: 22006369)
1. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States.
Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Gordon HS; Stewart AK; Ko CY; Bentrem DJ
Cancer; 2012 Jul; 118(13):3268-76. PubMed ID: 22006369
[TBL] [Abstract][Full Text] [Related]
2. Outcome of esophageal carcinoma in the veteran affairs population: a comparative analysis from the Veteran Affairs Central Cancer Registry.
Beg MS; Navaneethan U; Atiq M; Komrokji R; Safa M
Am J Clin Oncol; 2009 Jun; 32(3):286-90. PubMed ID: 19433959
[TBL] [Abstract][Full Text] [Related]
3. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy, with adjuvant surgery for local control, confers a durable survival advantage in adenocarcinoma and squamous cell carcinoma of the oesophagus.
Bass GA; Furlong H; O'Sullivan KE; Hennessy TP; Walsh TN
Eur J Cancer; 2014 Apr; 50(6):1065-75. PubMed ID: 24480403
[TBL] [Abstract][Full Text] [Related]
5. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
6. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
10. Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.
Courrech Staal EF; van Coevorden F; Cats A; Aleman BM; van Velthuysen ML; Boot H; Peeters MJ; van Sandick JW
Ann Surg Oncol; 2009 Dec; 16(12):3219-26. PubMed ID: 19777184
[TBL] [Abstract][Full Text] [Related]
11. Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: assessment of 987 hospitals.
Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Ko CY; Bentrem DJ
Ann Surg Oncol; 2012 Feb; 19(2):357-64. PubMed ID: 21769460
[TBL] [Abstract][Full Text] [Related]
12. Survival after esophageal resection for carcinoma: the importance of the histologic cell type.
Alexiou C; Khan OA; Black E; Field ML; Onyeaka P; Beggs L; Duffy JP; Beggs DF
Ann Thorac Surg; 2006 Sep; 82(3):1073-7. PubMed ID: 16928541
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the long-term outcomes of endoscopic resection for superficial squamous cell carcinoma and adenocarcinoma of the esophagus in Japan.
Nakagawa K; Koike T; Iijima K; Shinkai H; Hatta W; Endo H; Ara N; Uno K; Asano N; Imatani A; Shimosegawa T
Am J Gastroenterol; 2014 Mar; 109(3):348-56. PubMed ID: 24394751
[TBL] [Abstract][Full Text] [Related]
14. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.
Hölscher AH; Bollschweiler E; Schröder W; Metzger R; Gutschow C; Drebber U
Ann Surg; 2011 Nov; 254(5):802-7; discussion 807-8. PubMed ID: 22042472
[TBL] [Abstract][Full Text] [Related]
16. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
[TBL] [Abstract][Full Text] [Related]
18. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy.
Rohatgi PR; Swisher SG; Correa AM; Wu TT; Liao Z; Komaki R; Walsh GL; Vaporciyan AA; Rice DC; Bresalier RS; Roth JA; Ajani JA
Cancer; 2006 Feb; 106(3):552-8. PubMed ID: 16353210
[TBL] [Abstract][Full Text] [Related]
19. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
[TBL] [Abstract][Full Text] [Related]
20. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
